The combination of effective molecular adjuvants can cause massive expansion of antigen-specific CD8 T cells and show previously unseen efficacy in vaccine and tumor models [51], so whether we can utilize them for the treatment of KSD deserves to be explored further in the future. This evidence concerns the gene CD8A and neoplasm.